TNFα, the target of NF-κB and prototypical pro-inflammatory cytokine, could enhance tumour invasion by facilitating the epithelial to mesenchymal transition, then augment the capacity of cancer cells to metastatize16. The gene discussed is NFKB1; the disease is cancer.